Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
An overview of index funds with the lowest fees for retirement in 2024, highlighting how fees affect long-term returns and what to consider.
27,284 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Investors cheered a strong tesla quarterly deliveries jump, yet the stock traded lower. This article unpacks the reas...
PepsiCo drives growth with international momentum while Procter & Gamble shines in beauty; both set the stage for a d...
Dive into how to read myriad genetics (mygn) 2025 earnings transcripts, spot growth drivers, assess risk, and build a...
During a housing correction, buyers and homeowners rethink loan choices. This guide breaks down what we’re buying dur...
Investors are buzzing about Uber stock soaring? as the company moves toward stronger profitability and disciplined gr...
Tilray has cleared several hurdles, but a true breakout depends on one pivotal development. This guide breaks down th...
When a top executive sells stock, investors ask: Is this a red flag or routine planning? This guide breaks down the 9...
Broadcom’s latest results point to strong AI-chip momentum even as the market reacts. This article breaks down what t...
Plug Power aims to become profitable by 2028. This article breaks down the plan, the main risks, and concrete steps i...
As inflation sticks and volatility rises, investors are eyeing defensive income. This story flags five high-yield div...
AI-first cloud services are redefining how businesses run. This article breaks down the neocloud revolution here. thi...